A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma.
作者信息
DeStefano Vincent M, Wada Masayuki, Pinz Kevin G, Assi Rita, Zhang Hongyu, Wang Weijia, Zhang Wenli, Shah Darshi, Ma Yupo, Salman Huda
机构信息
Research & Development Division, iCell Gene Therapeutics Inc., Long Island High Technology Incubator, Stony Brook, New York, USA.
Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
出版信息
Clin Transl Med. 2024 Jul;14(7):e1743. doi: 10.1002/ctm2.1743.
Abstract
摘要
Zotero 插件